Compare VYGR & CZWI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VYGR | CZWI |
|---|---|---|
| Founded | 2013 | 1938 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 236.0M | 194.1M |
| IPO Year | 2015 | 2006 |
| Metric | VYGR | CZWI |
|---|---|---|
| Price | $3.95 | $20.51 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $21.00 | N/A |
| AVG Volume (30 Days) | ★ 624.9K | 45.4K |
| Earning Date | 05-05-2026 | 04-27-2026 |
| Dividend Yield | N/A | ★ 2.05% |
| EPS Growth | N/A | ★ 8.96 |
| EPS | N/A | ★ 1.46 |
| Revenue | ★ $10,135,000.00 | N/A |
| Revenue This Year | $34.04 | $13.02 |
| Revenue Next Year | $7.92 | $9.42 |
| P/E Ratio | ★ N/A | $14.06 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.65 | $13.15 |
| 52 Week High | $5.55 | $20.94 |
| Indicator | VYGR | CZWI |
|---|---|---|
| Relative Strength Index (RSI) | 50.43 | 70.82 |
| Support Level | $3.72 | $17.38 |
| Resistance Level | $4.30 | N/A |
| Average True Range (ATR) | 0.22 | 0.34 |
| MACD | -0.01 | 0.06 |
| Stochastic Oscillator | 55.45 | 82.84 |
Voyager Therapeutics Inc is a biotechnology company to leverage the power of human genetics to modify the course of and ultimately cure neurological diseases. Its pipeline includes programs for Alzheimer's disease, or AD; Friedreich's ataxia, or FA; Parkinson's disease, or PD; and multiple other diseases of the central nervous system, or CNS. Many of its programs are derived from its TRACER (Tropism Redirection of AAV by Cell-type-specific Expression of RNA) adeno-associated virus, or AAV, capsid discovery platform, which the company has used to generate novel capsids, or TRACER Capsids, and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous, or IV, dosing. Its segment is developing and commercializing genetic medicine.
Citizens Community Bancorp Inc is a bank holding company that offers traditional community banking services to businesses, Agricultural operators, and consumers, including one-to-four-family residential mortgages. it also offers a variety of loan products including commercial real estate loans, commercial and industrial (C&I) loans, agricultural real estate loans, agricultural operating loans, residential mortgages, home equity lines-of-credit, and consumer loans and offers deposit products through its branches, including demand deposits, various savings and money-market accounts and certificates of deposit. The company's sources of funds are deposits; amortization, prepayments, and maturities of outstanding loans; other short - term investments; and funds provided from operations.